HUP9601392A3 - Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor - Google Patents

Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor

Info

Publication number
HUP9601392A3
HUP9601392A3 HU9601392A HUP9601392A HUP9601392A3 HU P9601392 A3 HUP9601392 A3 HU P9601392A3 HU 9601392 A HU9601392 A HU 9601392A HU P9601392 A HUP9601392 A HU P9601392A HU P9601392 A3 HUP9601392 A3 HU P9601392A3
Authority
HU
Hungary
Prior art keywords
induce
growth factor
immune response
factor receptor
epidermal growth
Prior art date
Application number
HU9601392A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HU9601392D0 publication Critical patent/HU9601392D0/hu
Publication of HUP9601392A2 publication Critical patent/HUP9601392A2/hu
Publication of HUP9601392A3 publication Critical patent/HUP9601392A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9601392A 1995-05-26 1996-05-23 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor HUP9601392A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95107967 1995-05-26

Publications (3)

Publication Number Publication Date
HU9601392D0 HU9601392D0 (en) 1996-07-29
HUP9601392A2 HUP9601392A2 (en) 1997-03-28
HUP9601392A3 true HUP9601392A3 (en) 2000-08-28

Family

ID=8219291

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9601392A HUP9601392A3 (en) 1995-05-26 1996-05-23 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor

Country Status (15)

Country Link
US (1) US5969107A (hu)
JP (1) JPH08325299A (hu)
KR (1) KR960040375A (hu)
CN (1) CN1142505A (hu)
AT (1) ATE208403T1 (hu)
AU (1) AU710159B2 (hu)
CA (1) CA2177328A1 (hu)
CZ (1) CZ289357B6 (hu)
DE (1) DE69616651D1 (hu)
HU (1) HUP9601392A3 (hu)
MX (1) MX9601930A (hu)
NO (1) NO962125L (hu)
PL (1) PL314414A1 (hu)
SK (1) SK67496A3 (hu)
ZA (1) ZA964207B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924359B1 (en) * 1999-07-01 2005-08-02 Yale University Neovascular-targeted immunoconjugates
JP4263485B2 (ja) * 2001-02-07 2009-05-13 ヴィレックス アクチェンゲゼルシャフト ハイブリドーマ細胞系ｇ２５０およびモノクローナル抗体を製造するためのその使用
WO2003092693A1 (en) * 2002-05-06 2003-11-13 Washington University Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
CN104059147A (zh) * 2003-06-27 2014-09-24 艾默根佛蒙特有限公司 针对表皮生长因子受体的缺失突变体的抗体及其使用
JP2010513321A (ja) * 2006-12-22 2010-04-30 ノヴェリクス・セラピューティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 少なくとも一種の上皮細胞増殖因子受容体特異抗体またはその誘導体を用いる糖尿病の治療
WO2011097633A2 (en) * 2010-02-08 2011-08-11 Board Of Regents, The University Of Texas System Egf receptor mimicking peptides
DK3252076T3 (da) 2011-01-14 2019-12-02 Univ California Diagnostisk anvendelse af antistoffer mod ror-1-protein
CN109306010B (zh) * 2017-07-26 2022-07-19 石家庄以岭药业股份有限公司 表皮生长因子受体抗体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141783B2 (en) * 1983-11-07 1993-06-16 The Wistar Institute Immune response to tumours and viruses induced by anti-idiotype antibodies
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US4918164A (en) * 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US5459061A (en) * 1990-01-26 1995-10-17 W. Alton Jones Cell Science Center, Inc. Hybridomas producing monoclonal antibodies which specifically bind to continuous epitope on the human EGF receptor and compete with EGF for binding to the EGF receptor
CA2082160C (en) * 1991-03-06 2003-05-06 Mary M. Bendig Humanised and chimeric monoclonal antibodies
US5344760A (en) * 1991-06-03 1994-09-06 Ciba Corning Diagnostics Corp. Method of cancer detection
EP0586002B1 (en) * 1992-08-18 2000-01-19 CENTRO de IMMUNOLOGIA MOLECULAR Monoclonal antibodies recognizing the epidermal growth factor receptor, cells and methods for their production and compositions containing them

Also Published As

Publication number Publication date
AU710159B2 (en) 1999-09-16
AU5242296A (en) 1996-12-05
US5969107A (en) 1999-10-19
KR960040375A (ko) 1996-12-17
NO962125L (no) 1996-11-27
JPH08325299A (ja) 1996-12-10
CZ289357B6 (cs) 2002-01-16
SK67496A3 (en) 1996-12-04
HU9601392D0 (en) 1996-07-29
ZA964207B (en) 1996-12-04
NO962125D0 (no) 1996-05-24
CZ152596A3 (en) 1996-12-11
MX9601930A (es) 1997-01-31
PL314414A1 (en) 1996-12-09
DE69616651D1 (de) 2001-12-13
CA2177328A1 (en) 1996-11-27
HUP9601392A2 (en) 1997-03-28
ATE208403T1 (de) 2001-11-15
CN1142505A (zh) 1997-02-12

Similar Documents

Publication Publication Date Title
ZA964820B (en) Method for obtaining receptor angonist antibodies
EP0823941A4 (en) HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
IL136335A0 (en) Monoclonal human natural antibodies
PL323587A1 (en) Gene changing-over system including edisone receptor
IL128406A0 (en) Monoclonal antibodies
HUP9900754A3 (en) Vitronectin receptor antagonists
GB9603256D0 (en) Antibodies
IL125034A0 (en) Vitronectin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
EP0739962A3 (en) Self-leveling silicone polish
EP0809806A4 (en) MONOCLONAL ANTIBODIES AGAINST SURFACE ANTIGENS OF OSTEOGENIC CELLS
HUP9601392A2 (en) Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
EP0888126A4 (en) ANTI-IDIOTYPICAL ANTIBODY VACCINE
HUP9902817A3 (en) Endothelin receptor antagonists
HU9602054D0 (en) Endothelin receptor antagonists
EP0854721A4 (en) ENDOTHELIN RECEPTOR ANTAGONISTS
HU9600333D0 (en) Adhesive receptor antagonists
HUP9901579A3 (en) Antibodies specific for alpha-d-integrin
EP0508282A3 (en) Anti-idiotypic monoclonal antibodies
GB9718911D0 (en) Monoclonal antibodies
EP0973537A4 (en) IMMUNOGENS BINDING COCAETHYLENE AND ANTIBODIES
GB9804529D0 (en) Method for the detection of antigens or antibodies
EP0832124A4 (en) HUMAN AMINE RECEPTOR
EP0841916A4 (en) ENDOTHELINE RECEPTOR ANTAGONISTS